RhumbLine Advisers’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $3.59M | Sell |
|
|||||
|
2024
Q1 | $4.36M | Buy |
|
|||||
|
2023
Q4 | $4M | Buy |
|
|||||
|
2023
Q3 | $1.91M | Sell |
|
|||||
|
2023
Q2 | $2.81M | Buy |
|
|||||
|
2023
Q1 | $2.04M | Buy |
|
|||||
|
2022
Q4 | $2.52M | Buy |
|
|||||
|
2022
Q3 | $1.97M | Buy |
|
|||||
|
2022
Q2 | $1.65M | Buy |
|
|||||
|
2022
Q1 | $1.44M | Buy |
|
|||||
|
2021
Q4 | $1.19M | Sell |
|
|||||
|
2021
Q3 | $1.08M | Buy |
|
|||||
|
2021
Q2 | $724K | Buy |
|